
Fusion Pharmaceuticals Announces IND Clearance For FPI-2068, A Jointly Developed Novel Targeted Alpha Therapy
This press release was originally published by Fusion Pharmaceuticals on April 12, 2023. Read the original post here. FPI-2068 is
This press release was originally published by Fusion Pharmaceuticals on April 12, 2023. Read the original post here. FPI-2068 is
Making a smart site selection could drive the commercialization of your intellectual property. Here are three examples that are helping
This press release was originally published by Fusion Pharmaceuticals on April 12, 2023. Read the original post here. FPI-2068 is
Making a smart site selection could drive the commercialization of your intellectual property. Here are three examples that are helping to make Hamilton, Ontario, the next leader in life sciences research and commercialization.
Get the latest updates delivered straight to your inbox! Stay notified about companies on the grow, the latest tech trends, funding news and opportunities, industry insights, upcoming events and more from across Hamilton’s innovation ecosystem.